Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00122642Phase 3Completed
Phase 3, randomised, double-blind trial in catheter-related bloodstream infection (CRBSI) comparing Ethanol Lock with Placebo Lock (2 arms). Primary endpoint: Endoluminal catheter related bacteremia. Started Aug 2005; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00122642.